• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page
Why People Won’t Quit a Weight Loss Drug—Even When It Makes Them Feel Sick.

Why People Won’t Quit a Weight Loss Drug—Even When It Makes Them Feel Sick.

by William Jester | Mar 20, 2026 | Community, News

Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as effective, even when facing unpleasant side effects, according to Rutgers Health researchers. Their study, published in Journal of Medical...
Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment.

Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment.

by William Jester | Mar 19, 2026 | Community, News

When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how they grow, evade immunity or respond to treatment. But do...

New Jersey bans some products with toxic PFAS chemicals. Here’s what to know.

by William Jester | Mar 18, 2026 | Community, News

Toxic PFAS chemicals have tainted water, air and soil in the U.S. for decades. The so-called “forever” chemicals don’t break down naturally in the environment and can remain in the human bloodstream for years. New Jersey lawmakers have taken action to reduce one...
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients.

How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients.

by William Jester | Mar 17, 2026 | Community, News

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science Advances found low-protein diets slowed liver tumor growth and cancer...

Join NJ ACTS Clinical Research Management Collaborative Series on 3/31 from 12-1:30

by Pamela Dahlen | Mar 17, 2026 | News

Uterine Fibroids Webinar – Eliminating Barriers to Research and Care Advancing awareness, addressing disparities, and empowering patients through education to improve research participation and access to care. This session will explore critical challenges surrounding...
« Older Entries

Recent Posts

  • Why People Won’t Quit a Weight Loss Drug—Even When It Makes Them Feel Sick.
  • Rutgers Develops New Tool for Examining Cancer Genomic Data that Could Improve Treatment.
  • New Jersey bans some products with toxic PFAS chemicals. Here’s what to know.
  • How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients.
  • Join NJ ACTS Clinical Research Management Collaborative Series on 3/31 from 12-1:30

Archives

  • 2026
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,452)
  • Covid (998)
  • CTO Events (6)
  • News (3,106)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.